¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sickle cell hemoglobin"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® hemoglobin ÇÑ±Û Ç÷»ö¼Ò
¼³¸í   
  Ã´Ãßµ¿¹°ÀÇ ÀûÇ÷±¸ ¼Ó¿¡ ´Ù·®À¸·Î µé¾îÀִ »ö¼Ò´Ü¹éÁú. Ã¶À» Ç°´Â Æ÷¸£ÇǸ° °í¸®¿Í ´Ü¹éÁúÀÇ ÀÏÁ¾(±Û·Îºó)À¸·Î µÇ¾î ÀÖ´Ù. Ã¶(Fe)¿¡´Â »ê¼Ò¿Í °¡¿ªÀûÀ¸·Î °áÇÕÇϴ ´É·ÂÀÌ ÀÖ¾î, »ýü ³»¿¡¼­´Â »ê¼Ò¸¦ ¿î¹ÝÇϴ ÀÏÀ» ÇÑ´Ù. Ç÷»ö¼Ò ÇÑ ºÐÀڴ ³× °³ÀÇ Æú¸®ÆéƼµå »ç½½·Î µÇ¾î ÀÖ°í, °¢°¢ÀÇ Æú¸®ÆéƼµå »ç½½¿¡´Â ÇÑ °³¾¿ÀÇ ÇðÀÌ ÇÔÀ¯µÇ¾î ÀÖ´Ù. µû¶ó¼­ Ç÷»ö¼Ò ÇÑ ºÐÀÚ¿¡´Â Ã¶¿øÀÚ°¡ ³× °³ ÇÔÀ¯µÇ°í, Ã¶¿øÀÚ ÇÑ °³¿¡ ´ëÇØ ÇÑ ºÐÀÚ¾¿ÀÇ »ê¼Ò°¡ °áÇÕÇϹǷÎ, Ç÷»ö¼Ò ÇÑ ºÐÀÚ¿¡´Â »ê¼Ò 4ºÐÀÚ°¡ °áÇÕÇÑ´Ù. Ç÷»ö¼Ò´Â »ê¼Ò¾ÐÀÌ ³ôÀº ÇãÆÄ³ª ¾Æ°¡¹Ì¿¡¼­´Â »ê¼Ò¿Í °áÇÕÇϰí, »ê¼Ò¾ÐÀÌ ³·Àº Á¶Á÷¿¡ À̸£¸é »ê¼Ò¸¦ À¯¸®ÇÑ´Ù. ´õ¿íÀÌ »ê¼ÒÀÇ ¹æÃâÀº pH°¡ ³·¾ÆÁü¿¡ µû¶ó ÃËÁøµÇ¹Ç·Î, ÀÌ»êȭź¼Ò°¡ ¸¹°í pH°¡ ³·Àº ¸»ÃÊÁ¶Á÷¿¡¼­´Â »ê¼Ò¸¦ º¸´Ù À¯¸®Çϱ⠽±°Ô µÈ´Ù. ÀÌ»êȭź¼Ò´Â Ç÷Àå ¼Ó¿¡ ³ì¾Æ ÇãÆÄ¿¡ ¿î¹ÝµÇ¾î ÇãÆÄÈ£ÈíÀ¸·Î Ã¼¿Ü¿¡ ¹æÃâµÇ¸é pH´Â ´Ù½Ã ¿ø»óÅ·Πµ¹¾Æ°¡°í Ç÷»ö¼Ò´Â ´Ù½Ã »ê¼Ò¿Í °áÇÕÇÑ´Ù. ºÐÀÚ·® ¾à 6,500ÀÇ »ö¼Ò´Ü¹éÁú·Î Ç÷¾× ¼Ó¿¡¼­ÀÇ ÇÔÀ¯·®Àº Ç÷¾× 100 mLÁßÀÇ ±×·¥¼ö·Î ³ªÅ¸³½´Ù. Á¤»óÄ¡´Â ³²ÀÚ 16g/dL(14~18g/dL), ¿©ÀÚ 14g/dL (12~16g/dL)ÀÌ´Ù.
¿µ¹® muscle cell(=muscle fiber) ÇÑ±Û ±ÙÀ°¼¼Æ÷
¼³¸í   
  ±ÙÀ°Àº ¼öÀDZÙ(ÀǽĿ¡ ÀÇÇØ¼­ Á¶ÀýÀÌ °¡´ÉÇÑ ±ÙÀ°: ¿¹¸¦ µé¾î ´Ù¸®, ÆÈ, ¾ó±¼±ÙÀ° µî)°ú ºÒ¼öÀDZÙ(Àǽİú ¹«°üÇϰԠÁ¶ÀýÇÏÁö ¾Ê¾Æµµ ¿òÁ÷À̴ ±ÙÀ°: ¿¹¸¦ µé¾î ½ÉÀå±Ù, ¼ÒÈ­±â°ü¿¡ ºÐÆ÷Çϴ ±ÙÀ° µî)À¸·Î ³ª´©¾îÁö¸ç, ±ÙÀ°¼¼Æ÷ÀÇ ¸ð¾çÀº ´ÙÀ½°ú °°´Ù(¼öÀDZÙ, ºÒ¼öÀDZ٠¿Ü¿¡ ½ÉÀå¿¡ Àִ ½ÉÀå±ÙÀº ºÒ¼öÀDZٿ¡ ÇØ´çÇÏÁö¸¸ ±× ¸ð¾çÀº ¼öÀDZٰú °°¾Æ µû·Î ºÐ·ùÇÑ´Ù).
  
  ±ÙÀ°¼¼Æ÷
¿µ¹® white blood cell(WBC), leukocyte ÇÑ±Û ¹éÇ÷±¸
¼³¸í   
  Ç÷¾×³»¿¡ °ñ¼ö±¸°è¼¼Æ÷¿Í ¸²ÇÁ°è¼¼Æ÷, ´ÜÇÙ±¸°è¼¼Æ÷¸¦ ¸ðµÎ ÅëÆ²¾î ¸»ÇÑ´Ù. ¹éÇ÷±¸ÀÇ Áõ°¡°¡ ÀÖÀ¸¸é ´ë°³ °¨¿°ÀÌ Àְųª, È¤Àº Å»¼öÇö»óÀÌ ÀÖÀ½À» ÀǹÌÇÑ´Ù. ¶ÇÇÑ Áö³ªÄ£ ¹éÇ÷±¸¼öÀÇ °¨¼Ò´Â ÀÎü³» ¸é¿ª±â´ÉÀÌ ¶³¾îÁ® ÀÖÀ½À» ÀǹÌÇϸç, ´Ù¸¥ Áúº´¿¡ ÀÇÇØ ³ªÅ¸³ª´Â ÀÌÂ÷ÀûÀΠÇö»óÀÌ ¾Æ´ÑÁö ²À Áø´ÜÀ» ¹Þ¾Æº¸¾Æ¾ß ÇÑ´Ù.
¿µ¹® mast cell ÇÑ±Û ºñ¸¸ ¼¼Æ÷
¼³¸í   
  µ¿¹°ÀÇ °áÇÕ Á¶Á÷ °¡¿îµ¥ ³Î¸® ºÐÆ÷Çϴ ¼¼Æ÷. °áÇÕÁ¶Á÷°ú Á¡¸·Á¶Á÷ ³»¿¡ Àִ ȣ¿°±â¼º »ö¼Ò·Î ÀÌ¿°»ö¼º(metachromasia)À» ³ªÅ¸³»´Â °ú¸³À» °¡Áø ¹æÃßÇüÀÇ ¼¼Æ÷¿¡ ÀÛÀº µÕ±Ù ÇÙÀ» °¡Áø´Ù. ºñ¸¸¼¼Æ÷ÀǠǥ¸é¿¡´Â IgE¿¡ ´ëÇÑ ¼ö¿ëü°¡ Á¸ÀçÇϸç, ¼ö¿ëü¿¡ °áÇÕÇÑ IgE ºÐÀڵ鳢¸® ´Ù°¡ÀÇ Ç׿ø¿¡ ÀÇÇØ ¼­·Î ¿¬°áµÇ¸é ºñ¸¸¼¼Æ÷ °ú¸³Å»Ãâ ¹ÝÀÀÀÌ ÀϾ, È÷½ºÅ¸¹Î, ¼¼·ÎÅä´Ñ, ÇìÆÄ¸° µîÀÇ È­ÇÐÀü´Þ ¹°ÁúÀÌ ¹æÃâµÇ¾î, Áï½ÃÇü ¾Ë·¹¸£±â ¹ÝÀÀ µîÀÇ Áõ»óÀ» ÀÏÀ¸Å²´Ù. ÇǺÎ, À帷, Ç÷°ü ÁÖÀ§, Á¡¸· ÁÖº¯¿¡ ÀÖ´Ù.
¿µ¹® cell ÇÑ±Û ¼¼Æ÷
¼³¸í   
  »ý¸íü¸¦ ÀÌ·ç´Â ±¸Á¶Àû, ±â´ÉÀû ´ÜÀ§.
  
  ÇÙÀÇ À¯¹«¿¡ µû¶ó¼­ À¯ÇÙ¼¼Æ÷¿Í ¹«ÇÙ¼¼Æ÷·Î ³ª´­ ¼ö°¡ ÀÖ´Ù. ¹«ÇÙ¼¼Æ÷¶õ ÇÙÀÌ ¾ø´Â ¼¼Æ÷¸¦ ¸»ÇÑ´Ù. ÇÙÀ̶õ À¯ÀüÁ¤º¸¸¦ °¡Áö°í Àִ ¿°»öü¸¦ º¸°üÇϴ °÷Àε¥ ¹«ÇÙ¼¼Æ÷¿¡¼­´Â ¿°»öü°¡ ¼¼Æ÷¼Ó¿¡ ±×³É ³ëÃâµÇ¾î ÀÖ´Ù. ´ë°³ ¼¼Æ÷ ÇϳªÇϳª°¡ µ¶¸³µÈ »ý¸íüÀÇ ¿ªÇÒÀ» Çϴ ´Ü¼¼Æ÷»ý¹°·Î¼­ ¿ÜºÎȯ°æÀ¸·ÎºÎÅÍ ÀÚ½ÅÀ» º¸È£ÇÒ ¼ö Àִ °ß°íÇÑ ¼¼Æ÷º®À» °¡Áö°í ÀÖ´Ù. À¯ÇÙ¼¼Æ÷¶õ ÇÙÀ» °¡Áö°í À־ À¯ÀüÁ¤º¸°¡ Àִ ¿°»öü°¡ ¼¼Æ÷ÀÇ ´Ù¸¥ ºÎºÐ°ú ±¸ºÐµÇ¾î ÇÙ¼Ó¿¡ µé¾îÀÖ´Ù. ¼¼Æ÷¼Ó¿¡¼­ ÇÙ¿ÜÀÇ ºÎºÐ(À̸¦ ¼¼Æ÷ÁúÀ̶ó ÇÑ´Ù)¿¡´Â ¿©·¯ °¡Áö ¼¼Æ÷ÀÇ ¼Ò±â°üÀÌ À־ ¼¼Æ÷ÀÇ ´Ù¾çÇÑ ±â´ÉÀ» ºÐ´ãÇÑ´Ù.
  
  ¢ÂÀ¯ÇÙ¼¼Æ÷ÀÇ ±âº» ±¸Á¶
  
  1.¼¼Æ÷¸·-¼¼Æ÷¸¦ µÑ·¯½Î¼­ ÁÖÀ§È¯°æ°ú ºÐ¸®ÇÏ¿© ¼¼Æ÷ÀÇ ³»È¯°æÀ» À¯ÁöÇÑ´Ù.
  
  2.ÇüÁú³»¼¼¸Á(endoplasmic reticulum)-´ÜÀ§¸·À¸·Î µÑ·¯½×¿© Àִ ºÒ±ÔÄ¢ÇÑ ¸Á»ó±¸Á¶ÀÌ´Ù. ÀÌ ¸Á»ó±¸Á¶ÀÇ ³»ºÎ¸¦ ¼Ò°­, ¼ÒÁ¶¶ó°í ºÎ¸¥´Ù. ¿©±â¿¡´Â Ç¥¸éÀÌ ¸Å²öÇÑ ¹«°ú¸³ÇüÁú³»¼¼¸Á°ú Ç¥¸éÀÌ ºÒ±ÔÄ¢ÇÑ °ú¸³ÇüÁú³»¼¼¸ÁÀÇ µÎ °¡Áö°¡ ÀÖ´Ù. °ú¸³ÇüÁú³»¼¼¸ÁÀÇ °æ¿ì´Â Ç¥¸é¿¡ ´Ü¹éÁúÀ» ÇÕ¼ºÇϴ ¸®º¸¼ØÀ̶ó´Â °ÍÀÌ ºÎÂøµÇ¾î ÀÖ´Ù. À̰÷Àº ÁַΠ¼¼Æ÷¹ÛÀ¸·Î ºÐºñÇÒ ´Ü¹éÁúÀ» ÇÕ¼ºÇϴ Àå¼ÒÀÌ´Ù. ¹«°ú¸³ÇüÁú³»¼¼¸ÁÀº Ç¥¸é¿¡ ¸®º¸¼ØÀÌ ºÎÂøµÇ¾î ÀÖÁö ¾ÊÀº °ÍÀ» ¸»Çϸç, À̰÷¿¡¼­´Â ÁÖ·Î ÇØµ¶ÀÛ¿ë, ±Û¸®ÄÚ°ÕÀÇ ÇÕ¼º, ½ºÅ×·ÎÀ̵åÈ£¸£¸óÀÇ ÇÕ¼º µîÀÌ ÀϾ´Ù.
  
  3.¸®º¸¼Ø-´Ü¹éÁúÀ» ÇÕ¼ºÇϴ ¿ªÇÒÀ» Çϴ °÷ÀÌ´Ù.À̰ÍÀº ¼¼Æ÷Áú¿¡ Á¸ÀçÇϴ ÀÚÀ¯¸®º¸¼Ø°ú °ú¸³ÇüÁú³»¼¼¸Á¿¡ ºÎÂøÀÌ µÇ¾î Á¸ÀçÇϴ ºÎÂø¸®º¸¼ØÀÇ µÎ °¡Áö·Î ³ª´«´Ù. ÀÚÀ¯¸®º¸¼ØÀº ÁַΠ¼¼Æ÷³»¿¡¼­ ÇÊ¿äÇÑ ´Ü¹éÁúÀ» ¸¸µå´Â ¿ªÇÒÀ» Ç졒ʼÎÂø¸®º¸¼ØÀº ¼¼Æ÷¹ÛÀ¸·Î ºÐºñÇÒ ´Ü¹éÁúÀ» ¸¸µå´Â ¿ªÇÒÀ» ÇÑ´Ù.
  
  4.°ñÁöÀåÄ¡(Golgi apparatus)-ÇÙÁÖÀ§¿¡ ºÐÆ÷Çϴ ³³ÀÛÇØÁø ÁָӴϸð¾çÀÇ °ÍÀÌ ÁßøµÇ¾î Çü¼ºµÈ ÃþÆÇ ¸ð¾çÀÇ ±¸Á¶¹°·Î °ú¸³ÇüÁú³»¼¼¸Á¿¡¼­ »ý¼ºµÇ¾î ¿ÜºÎ·Î ºÐºñµÉ ´Ü¹éÁúÀ» ¸ð¾Æ¼­ ³óÃà, Æ÷ÀåÇÏ¿© °ú¸³À» ¸¸µå´Â ¿ªÇÒÀ» ÇÑ´Ù.
  
  5.»ç¸³Ã¼(mitochondria)-±¸Çü, ³­ÇüÀÇ ±ä ¸·´ë±â ¸ð¾çÀ¸·Î Å©±â°¡ ´Ù¾çÇÑ ±¸Á¶¹°. »ý¹°Ã¼ÀÇ ¿¡³ÊÁö ÀúÀå¹°ÁúÀΠATP¸¦ »ý»êÇϴ ¿ªÇÒÀ» ÇÑ´Ù. ¶Ç ¼¼Æ÷¿Í ´Ù¸¥ ÀڽŸ¸ÀÇ À¯ÀüÁ¤º¸¸¦ °¡Áø DNA, RNA¸¦ °¡Áö°í ÀÖ´Ù. ¸ð¾ç, Å©±â°¡ ¼¼±Õ°ú ºñ½ÁÇϸç ÀÚüÁõ½Ä¼º µî µ¶¸³µÈ »ý¸íü·Î¼­ ÇÊ¿äÇÑ ¿ä°ÇÀ» °®Ãß°í À־ ¼¼Æ÷¿Í °ø»ý°ü°è¸¦ °¡Áø µ¶¸³µÈ ¼¼Æ÷·Î »ý°¢Çϰí ÀÖ´Ù.
  
  6.¿ëÇØ¼Òü(lysosome)-ÀÛÀº ±¸ÇüÀÇ ¼Òü·Î ¿©·¯ °¡Áö ºÐÇØÈ¿¼Ò¸¦ °¡Áø´Ù. ¼¼Æ÷¿Ü°è¿¡¼­ µé¾î¿Â ¹°Áú°ú °áÇÕÇÏ¿© ±× ¹°ÁúµéÀ» ¿ëÇØÇϴ ¿ªÇÒÀ» Çϰí, ¿À·¡µÈ ¼¼Æ÷¼Ò±â°üµéÀ» Á¦°ÅÇϴ ¿ªÇÒµµ ÇÑ´Ù.
  
  7.¼¼Æ÷ÇÙ(nucleus)-±¸Çü, ³­ÇüÀ¸·Î ¼¼Æ÷ÀÇ Á߽ɿ¡ À§Ä¡ÇÑ´Ù. ÇÙ³»¿¡´Â À¯ÀüÁ¤º¸°¡ Àִ ¹°ÁúÀΠ¿°»öü°¡ Á¸ÀçÇÑ´Ù.
  
  8.Á߽ɼÒü(centrosome)-ÇÙÁÖÀ§¿¡ Á¸ÀçÇϸ鼭 ÇÙÀÇ ºÐ¿­½Ã¿¡ ¾çÂÊÀÇ ¿°»öü¸¦ ´ç±â´Â ÀÛÀº ¼¶À¯¸¦ ¸¸µå´Â ¿ªÇÒÀ» Çϴ °÷.
  
  ¼¼Æ÷
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sickle cell
    ³´ÀûÇ÷±¸
  • sickle cell anemia
    ³´ÀûÇ÷±¸ºóÇ÷, °â»óÀûÇ÷±¸ºóÇ÷
  • sickle cell disease
    ³´ÀûÇ÷±¸º´
  • sickle cell retinopathy
    ³´ÀûÇ÷±¸¸Á¸·º´(Áõ)
  • sickle cell trait
    ³´ÀûÇ÷±¸¼ÒÁú, ³´¼¼Æ÷¼ºÇâ
  • denatured hemoglobin
    º¯¼ºÇ÷»ö¼Ò
  • fast hemoglobin
    ±Þ¼ÓÇ÷»ö¼Ò
  • fetal hemoglobin
    žÆÇ÷»ö¼Ò
  • glycosylated hemoglobin
    ´çÈ­Çì¸ð±Û·Îºó
  • hemoglobin
    Ç÷»ö¼Ò, Çì¸ð±Û·Îºó
  • hemoglobin absorption curve
    Çì¸ð±Û·ÎºóÈí¼ö°î¼±
  • hemoglobin C
    Çì¸ð±Û·ÎºóC
  • hemoglobin C disease
    Çì¸ð±Û·ÎºóCº´
  • hemoglobin disease
    Çì¸ð±Û·Îºóº´, Ç÷»ö¼Òº´
  • hemoglobin E disease
    Çì¸ð±Û·ÎºóEº´
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sickle cell anemia
    ³´ÀûÇ÷±¸ºóÇ÷
  • sickle cell trait
    ³´¼¼Æ÷¼ÒÁú, ³´ÀûÇ÷±¸Çü¼º¼ÒÁú
  • hemoglobin electrophoresis
    Ç÷»ö¼ÒÀü±âÀ̵¿, Ç÷»ö¼ÒÀü±â¿µµ¿
  • hemoglobin
    Ç÷»ö¼Ò
  • reduced hemoglobin
    ȯ¿øÇ÷»ö¼Ò
  • cell
    ¼¼Æ÷
  • accessory cell
    º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
  • acinar cell
    »ù²Ê¸®¼¼Æ÷
  • amacrine cell
    ¹«Ãà»è¼¼Æ÷
  • balloon cell
    dz¼±¼¼Æ÷
  • basal cell
    ¹Ù´Ú¼¼Æ÷, ±âÀú¼¼Æ÷
  • basal cell carcinoma
    ¹Ù´Ú¼¼Æ÷¾ÏÁ¾, ±âÀú¼¼Æ÷¾ÏÁ¾
  • basket cell
    ¹Ù±¸´Ï¼¼Æ÷
  • basophilic cell
    È£¿°±â¼¼Æ÷
  • beta cell
    º£Å¸¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sickle cell anemia
    ³´ÀûÇ÷±¸ºóÇ÷
  • sickle cell
    ³´ÀûÇ÷±¸
  • sickle cell disease
    ³´ÀûÇ÷±¸º´, °â»óÀûÇ÷±¸º´
  • sickle cell meniscocyte
    ³´ÀûÇ÷±¸
  • sickle cell anemia meniscocytosis
    ³´ÀûÇ÷±¸ºóÇ÷
  • sickle-cell retinopathy
    ³´ÀûÇ÷±¸¸Á¸·º´Áõ
  • sickle cell trait
    ³´¼¼Æ÷¼ÒÁú, ³´ÀûÇ÷±¸Çü¼º¼ÒÁú
  • abnormal hemoglobin
    ÀÌ»óÇ÷»ö¼Ò
  • adult hemoglobin
    ¼ºÀÎÇ÷»ö¼Ò
  • carbon monoxide hemoglobin test
    ÀÏ»êȭź¼ÒÇì¸ð±Û·Îºó°Ë»ç
  • hemoglobin absorption curve
    Ç÷»ö¼ÒÈí¼ö°î¼±
  • mean corpuscular hemoglobin concentration
    Æò±ÕÀûÇ÷±¸Ç÷»ö¼Ò³óµµ
  • denatured hemoglobin
    º¯¼ºÇ÷»ö¼Ò
  • hemoglobin disease
    Çì¸ð±Û·Îºóº´, Ç÷»ö¼Òº´
  • hemoglobin encapsulation
    Ç÷»ö¼ÒÇdz¶
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Seidels sickle scotoma
    ÀÚÀ̵¨³´¸ð¾ç¾ÏÁ¡
  • MCH => mean cell hemoglobin
    Æò±ÕÀûÇ÷±¸Ç÷»ö¼Ò
  • NK cell [=natural killer cell]
    ÀÚ¿¬»ì»ó¼¼Æ÷
  • alpha cell glucagon cell
    ¾ËÆÄ¼¼Æ÷ ±Û·çÄ«°ï¼¼Æ÷
  • quiescent cell, Q cell
    Á¤Áö¼¼Æ÷
  • F hemoglobin fetal
    žƼº(÷Ãä®àõ) Çì¸ð±Û·Îºó
  • Fetal hemoglobin
    žÆÇ÷»ö¼Ò(÷Ãä®úìßäáÈ)
  • Hb A hemoglobin adult
    ¼ºÀÎÇü Çì¸ð±Û·Îºó
  • Hemoglobin-oxygen equilibrium curve
    Çì¸ð±Û·Îºó-»ê¼Ò°î¼±
  • MCH=£¾mean corpuscular hemoglobin
    Æò±ÕÀûÇ÷±¸Ç÷»ö¼Ò·®.
  • MCH=ÊÝmean corpuscular hemoglobin
    Æò±ÕÀûÇ÷±¸Ç÷»ö¼Ò·®.
  • MCHC=£¾mean corpuscular hemoglobin con centration
    Æò±ÕÀûÇ÷±¸Ç÷»ö¼Ò³óµµ.
  • MCHC=ÊÝmean corpuscular hemoglobin con centration
    Æò±ÕÀûÇ÷±¸Ç÷»ö¼Ò³óµµ.
  • abnormal hemoglobin
    ÀÌ»óÇ÷»ö¼Ò(~Ì´Ë×ËÛ), ÀÌ»óÇì¸ð±Û·Îºó.
  • adult hemoglobin =Hb A
    ¼ºÀÎÇü Çì¸ð±Û·Îºó<Ç÷»ö¼Ò>.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sickle hemoglobin
    °â»óÇì¸ð±Û·Îºó.
  • sickle hemoglobin
    °â»óÇì¸ð±Û·Îºó(ÌÇßÒ¡­)
  • autosplenectomy,in sickle cell disease
    °â»ó¼¼Æ÷º´(ÌÇßÒá¬øàÜ»)
  • sickle cell
    °â»óÀûÇ÷±¸(ÌÇßÒîåúìϹ)
  • sickle cell
    °â»ó(Àû)Ç÷±¸(ÌÇßÒîåúìϹ).
  • sickle cell
    °â»ó(Àû)Ç÷±¸(ÌÇßÒîåúìϹ)
  • sickle cell anemia
    °â»óÀûÇ÷±¸¼º ºóÇ÷
  • sickle cell anemia
    °â»óÀûÇ÷±¸ºóÇ÷
  • sickle cell anemia
    °â»ó(Àû)Ç÷±¸¼º ºóÇ÷ (¡­Þ¸úì).
  • sickle cell anemia
    °â»ó(Àû)Ç÷±¸¼º ºóÇ÷ (¡­Þ¸úì)
  • sickle cell disease
    °â»óÀûÇ÷±¸º´
  • sickle cell disease
    °â»ó(Àû)Ç÷±¸º´.
  • sickle cell disease
    °â»ó(Àû)Ç÷±¸º´(¡­)
  • sickle cell trait
    ÀûÇ÷±¸°â»óÇü¼º°æÇâ
  • sickle cell trait
    ÀûÇ÷±¸°â»óÇü¼º°æÇâ(îåúìϹÌÇßÒû¡à÷ÌËú¾).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Chief cell [Type I glomus cell]
    °ú¸³¼¼Æ÷
    [¿¾ ¿ë¾î] ÁÖ¼¼Æ÷(Á¦1Çü»ç±¸¼¼Æ÷)
  • Clear cell [Epinephrine cell]
    ¹àÀº¼¼Æ÷ [¿¡Çdz×ÇÁ¸°¼¼Æ÷]
    [¿¾ ¿ë¾î] ¸í¼¼Æ÷(¿¡Çdz×ÇÁ¸°ºÐºñ¼¼Æ÷)
  • Sustentacular cell [Sertoli cell]
    ¹öÆÀ¼¼Æ÷
    [¿¾ ¿ë¾î] ÁöÁÖ¼¼Æ÷
  • Beta cell [Insulin cell]
    º£Å¸¼¼Æ÷ [Àν´¸°¼¼Æ÷]
    [¿¾ ¿ë¾î] º£Å¸¼¼Æ÷
  • Secretory epithelial cell [Glandular cell]
    ºÐºñ»óÇǼ¼Æ÷ [»ù¼¼Æ÷]
    [¿¾ ¿ë¾î] ºÐºñ»óÇǼ¼Æ÷
  • Interstitial cell [Dark cell]
    »çÀÌÁú¼¼Æ÷
    [¿¾ ¿ë¾î] °£Áú¼¼Æ÷
  • Interstitial cell [Leydig`s cell]
    »çÀÌÁú¼¼Æ÷
    [¿¾ ¿ë¾î] °£Áú¼¼Æ÷
  • Bronchiolar cell [Clara cell]
    ¼¼±â°üÁö¼¼Æ÷
    [¿¾ ¿ë¾î] ºÐºñ¼¼Æ÷
  • Parafollicular cell [Calcitonin cell]
    ¼ÒÆ÷°ç¼¼Æ÷
    [¿¾ ¿ë¾î] ¼ÒÆ÷¹æ¼¼Æ÷
  • Neurolemmal cell [Schwann`s cell]
    ½Å°æÁý¼¼Æ÷
    [¿¾ ¿ë¾î] ½Å°æÃʼ¼Æ÷
  • Alpha cell [Glucagon cell]
    ¾ËÆÄ¼¼Æ÷ [±Û·çÄ«°ï¼¼Æ÷]
    [¿¾ ¿ë¾î] ¾ËÆÄ¼¼Æ÷
  • Dark cell [Norepinephrine cell]
    ¾îµÎ¿î¼¼Æ÷ [³ë¸£¿¡Çdz×ÇÁ¸°¼¼Æ÷]
    [¿¾ ¿ë¾î] ¾Ï¼¼Æ÷(³ë¸£¿¡Çdz×ÇÁ¸°ºÐºñ¼¼Æ÷)
  • Chief cell [Type I glomus cell]
    °ú¸³¼¼Æ÷
    [¿¾ ¿ë¾î] ÁÖ¼¼Æ÷
  • Supporting cell [Sertoli cell]
    ¹öÆÀ¼¼Æ÷
    [¿¾ ¿ë¾î] ÁöÁÖ¼¼Æ÷
  • Supporting cell [Type II glomus cell]
    ¹öÆÀ¼¼Æ÷
    [¿¾ ¿ë¾î] ÁöÁö¼¼Æ÷
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • excretory cell
    ¹è¼³¼¼Æ÷
  • flame cell
    ºÒ²É¼¼Æ÷
  • G cell G
    ¼¼Æ÷
  • germ cell
    ¹è¼¼Æ÷
  • interstitial plasma cell pneumonia
    °£Áú¼ºÇüÁú¼¼Æ÷Æó¿°
  • nurse cell
    º¸¸ð¼¼Æ÷
  • renette cell
    ¹è¼³¼¼Æ÷
  • tegumental cell
    Ç¥ÇǼ¼Æ÷
  • vitelline cell
    ³­È²¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sickle cell hemoglobin
    ³´¼¼Æ÷(á¬øà)È÷¸ð±Û·Îºó
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sickle cell
    ³´¼¼Æ÷(á¬øà)
  • sickle cell anemia
    ³´¼¼Æ÷(á¬øà)ºóÇ÷(Þ¸úì)
  • sickle cell disease
    ³´¼¼Æ÷(á¬øà)Áúȯ(òðü´)
  • sickle cell trait
    ³´¼¼Æ÷(á¬øà)¼ºÇâ(àõú¾)
  • abnormal hemoglobin
    ÀÌ»óÇ÷»ö¼Ò (ì¶ßÈúìßäáÈ)
  • carbon monoxide hemoglobin
    ÀÏ»êȭź¼Ò(ìéß«ûù÷©áÈ) Çì¸ð±Û·Îºó
  • fast hemoglobin
    ºü¸¥ È÷¸ð±Û·Îºó
  • fetal hemoglobin
    žÆ(÷Ãä®) È÷¸ð±Û·Îºó
  • hemoglobin
    È÷¸ð±Û·Îºó
  • hemoglobin switching
    È÷¸ð±Û·Îºó ¹Ù²Ù±â
  • hemoglobin variant
    È÷¸ð±Û·Îºó º¯ÀÌü(ܨì¶ô÷)
  • hybrid hemoglobin
    Æ¢±âÈ÷¸ð±Û·Îºó
  • slow hemoglobin
    ¿Ï¼Ó(èÐáÜ) È÷¸ð±Û·Îºó
  • absorption cell
    Èí¼ö¼Ò°ü (ýåâ¥á³Î·)
  • amplifier T cell
    Áõ½Ä T ¼¼Æ÷(ñòãÖ T á¬øà)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sickle-cell anemia
    °â»ó(Àû)Ç÷±¸¼ººóÇ÷
  • fetal hemoglobin
    žƼºÇì¸ð±Û·Îºó, žƼºÇ÷»ö¼Ò
  • hemoglobin
    Çì¸ð±Û·Îºó, Ç÷»ö¼Ò
  • acinar cell
    Æ÷»ó¼¼Æ÷
  • air cell
    ÇԱ⵿
  • alveolar cell carcinoma
    ÆóÆ÷¼¼Æ÷¾ÏÁ¾
  • basal cell carcinoma
    ±âÀú¼¼Æ÷¾ÏÁ¾
  • blast cell
    ¸ð¼¼Æ÷
  • blood cell
    Ç÷±¸
  • cell
    ¼¼Æ÷, ¹úÁý, ºÀ¼Ò, °ÇÀüÁö
  • chromaffin cell
    Å©·Òģȭ¼¼Æ÷
  • clear cell
    Åõ¸í ¼¼Æ÷
  • columnar cell
    ¿øÁÖ¼¼Æ÷
  • cuboidal cell
    ÀԹ漼Æ÷
  • daughter cell
    µþ¼¼Æ÷, ³¶¼¼Æ÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HbS hemoglobin S, sickle-cell hemoglobin
S-D sickle-cell hemoglobin D; suicide-depression
SF Sabin-Feldman [test]; safety factor; salt-free; scarlet fever; screen film; seminal fluid; serosal f...
SC conditioned stimulus; sacrococcygeal; Sanitary Corps; scalenus [muscle]; scapula; Schwann cell; scia...
SCA self-care agency; severe congenital anomaly; sickle-cell anemia; single-camera autostereoscopic [ima...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SCD Sickle Cell Disease
SCA Sickle cell anaemia
SCT Sickle cell trait
PSR Proliferative sickle retinopathy
MCHC Mean cell hemoglobin concentration
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • sickle cell anemia
    °â»ó ÀûÇ÷±¸ ºóÇ÷
    À¯Àü¼ºÀÇ ¿ëÇ÷¼º ºóÇ÷·Î¼­ ÀÌ»ó Ç÷»ö¼ÒÁõÀÇ ÇϳªÀ̸ç ÈæÀο¡°Ô¼­ ÁÖ·Î ³ªÅ¸³ª°í Ç÷¾×¿¡ °â»ó ÀûÇ÷±¸°¡ ÀÖ´Â °ÍÀÌ Æ¯Â¡ÀÌ´Ù.
  • sickle cell trait
    °â»ó ÀûÇ÷±¸ ¼ÒÁú
    »ê¼Ò ºÐ¾ÐÀÌ ³·Àºµ¥¼­ Æø·ÎµÈ ¶§ ÀûÇ÷±¸ÀÇ °â»óÈ­·Î ÀνĵǴ »ç¶÷ÀÇ »óÅÂ. °â»ó ÀûÇ÷±¸ ºóÇ÷°ú °ü°è°¡ ÀÖ´Â ´ë¸³À¯ÀüÀÚÀÇ ÇìÅ×·Î Á¢ÇÕ¿¡ ±âÀÎÇÑ´Ù.
  • sickle-cell anemia
    °â»ó ÀûÇ÷±¸ ºóÇ÷
    À¯ÀüÀûÀ¸·Î Çì¸ð±Û·Îºó º£Å¸ ±Û·Îºó chainÀÌ valineÀ¸·Î ¹Ù²î¾î ³´ ¸ð¾çÀÇ ÀûÇ÷±¸¸¦ »ý¼ºÇÏ´Â »óÅÂ. ÈæÀο¡°Ô¼­ ¸¹ÀÌ ¹ß»ýÇÑ´Ù.
  • sickle-cell trait
    ÀûÇ÷±¸ °â»óÇü¼º °æÇâ
  • adult hemoglobin
    ¼ºÀÎÇü Çì¸ð±Û·Îºó
  • fetal hemoglobin
    žƼº Çì¸ð±Û·Îºó
  • hemoglobin
    Ç÷»ö¼Ò, Çì¸ð±Û·Îºó
    1. 4°³ÀÇ Çð°ú ±Û·Îºó ´Ü¹éÁú·Î ±¸¼ºµÈ´Ù. 2. ö °áÇÕüÀÎ ÇðÀÌ »ê¼Ò¿Í °áÇÕÇÏ¿© Ç÷¾×ÀÇ »ê¼Ò¸¦ ¿î¹ÝÇÏ´Â ÀÛ¿ëÀ» ÇÏ¸ç ±× ¿Ü¿¡ ź»ê°¡½º ¿î¹Ý°ú »ê, ¿°±â ÆòÇüÀ» À¯ÁöÇÑ´Ù. 3. Ç÷¾× 100§¢´ç ¾à 15§·ÀÇ Ç÷»ö¼Ò¸¦ ÇÔÀ¯Çϰí ÀÖ´Ù. 4. È­ÇÐÀûÀ¸·Î ÀûÇ÷±¸¸¦ ÀÌ·ç°í ÀÖ´Â ÁÖ¿ä ¹°Áú·Î, ÁöÁú°ú ´Ü¹éÁúÀÇ º¹ÇÕü·Î ÀûÇ÷±¸ÀÇ »ö±òÀ» ³ªÅ¸³»´Â ÁÖµÈ ¹°ÁúÀÌ°í ºÎºÐÀûÀ¸·Î ÀûÇ÷±¸ÀÇ ÇüŸ¦ °áÁ¤Áþ±âµµ ÇÑ´Ù.
  • hemoglobin crystal
    Çì¸ð±Û·Îºó °áÁ¤, Ç÷»ö¼Ò °áÁ¤
  • mean corpuscular hemoglobin
    ÀûÇ÷±¸ÀÇ Æò±Õ Ç÷»ö¼Ò·®
    MCH´Â ÀûÇ÷±¸ ÇÑ °³ ÇÑ °³°¡ °¡Áö´Â Ç÷»ö¼Ò·®ÀÇ Æò±ÕÄ¡¸¦ ¥ì¥ìg¶Ç´Â ¥ã¥ã·Î Ç¥½ÃÇÑ °Í.
  • mean corpuscular hemoglobin concentration
    ÀûÇ÷±¸ÀÇ Ç÷»ö¼Ò Æò±Õ ³óµµ, Æò±Õ ÀûÇ÷±¸ Ç÷»ö¼Ò ³óµµ
    MCHC´Â ÇÑ °³ ÇÑ °³ÀÇ ÀûÇ÷±¸°¡ °¡Áö´Â Ç÷»ö¼Ò ³óµµÀÇ Æò±ÕÀ» %·Î Ç¥½ÃÇÑ °Í.
  • oxygenated hemoglobin
    »êÈ­ Çì¸ð±Û·Îºó, »ê¼Ò °áÇÕ Çì¸ð±Û·Îºó
  • plasma hemoglobin
    Ç÷Àå Çì¸ð±Û·Îºó, Ç÷Àå Ç÷¾×¼Ò
  • clear cell basal cell carcinoma
    Åõ¸í ¼¼Æ÷ ±âÀú¼¼Æ÷¾Ï
  • Abbe-Zeiss counting cell
    ¾Ðº£-ÀÚÀ̽º Ç÷±¸ °è»ê
  • abnormality of cell interaction
    ¼¼Æ÷ »óÈ£ÀÛ¿ë ÀÌ»ó
    ¼¼Æ÷ »çÀÌ¿¡ ÀϾ´Â ÀÛ¿ëÀÌ ºñÁ¤»óÀûÀÎ °Í.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
hemoglobin <cell biology, haematology> Four subunit globular oxygen carrying protein of the erythrocytes of vertebrates and some invertebrates.
It is a conjugated protein containing four haem groups and globin. There are two alpha and two beta chains (very similar to myoglobin) in adult humans, the haem moiety (an iron containing substituted porphyrin) is firmly held in a nonpolar crevice in each peptide chain.
There are four globin polypeptide chains, designated alpha, beta, gamma, delta in the adult. Each is composed of several hundred amino acids.
(08 Mar 2000)
anaemia, sickle cell A disease characterised by chronic haemolytic anaemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for haemoglobin s.
(12 Dec 1998)
sickle cell <haematology, pathology> An erythrocyte that changes from the normal discoid shape to a sickled shape when the oxygen tension is low.
The pesence of these cells indicates that the patient is homozygotes for the allele that codes for haemoglobin S and that the patient has sickle cell anaemia.
(18 Nov 1997)
sickle cell anaemia <haematology> Disease common in races of people from areas in which malaria is endemic.
The cause is a point mutation in the allele that codes for the beta chain of haemoglobin with a substitution of (valine for glutamic acid at position 6. The defective haemoglobin (HbS) crystallizes readily at low oxygen tension.
In consequence, erythrocytes from homozygotes change from the normal discoid shape to a sickled shape when the oxygen tension is low and these sickled cells become trapped in capillaries or damaged in transit, leading to severe anaemia.
In heterozygotes, the disadvantages of the abnormal haemoglobin are apparently outweighed by increased resistance to Plasmodium falciparum malaria, probably because parasitised cells tend to sickle and are then removed from circulation.
Symptoms include joint pain, acute abdominal pain, and ulcerations of the lower extremities.
Origin: Gr. Haima = blood
(18 Nov 1997)
sickle cell anaemia: bone manifestations <radiology> 8-13% of blacks carry sickling factor, symptoms: chronic ulcers, pain crises, many infections, priapism X-ray findings: deossification due to marrow hyperplasia, decreased bone density in skull with widened diploe, H-shaped vertebrae or fish vertebrae, rib notching, thrombosis and infarction, avascular necrosis, especially femoral head, periosteal treatmentn (bone within bone), secondary osteomyelitis, Staph. Aureus greater than Salmonella, dactylitis = hand foot syndrome, growth effects, bone shortening secondary to diminished blood supply, death less than 40y
(12 Dec 1998)
sickle cell C disease A disease resulting from abnormal sickle-shaped erythrocytes (containing haemoglobin C and S) which appear in response to a lowering of the partial pressure of oxygen; characterised by anaemia, crises due to haemolysis or vascular occlusion, chronic leg ulcers and bone deformities, and infarcts of bone or of the spleen.
(05 Mar 2000)
sickle cell crisis <haematology> Disease common in races of people from areas in which malaria is endemic.
The cause is a point mutation in the allele that codes for the beta chain of haemoglobin with a substitution of (valine for glutamic acid at position 6. The defective haemoglobin (HbS) crystallizes readily at low oxygen tension.
In consequence, erythrocytes from homozygotes change from the normal discoid shape to a sickled shape when the oxygen tension is low and these sickled cells become trapped in capillaries or damaged in transit, leading to severe anaemia.
In heterozygotes, the disadvantages of the abnormal haemoglobin are apparently outweighed by increased resistance to Plasmodium falciparum malaria, probably because parasitised cells tend to sickle and are then removed from circulation.
Symptoms include joint pain, acute abdominal pain, and ulcerations of the lower extremities.
Origin: Gr. Haima = blood
(18 Nov 1997)
sickle cell dactylitis <syndrome> Recurrent painful swelling of the hands and feet occurring in infants and young children with sickle cell anaemia.
Synonym: sickle cell dactylitis.
(05 Mar 2000)
sickle cell disease <haematology> Disease common in races of people from areas in which malaria is endemic.
The cause is a point mutation in the allele that codes for the beta chain of haemoglobin with a substitution of (valine for glutamic acid at position 6. The defective haemoglobin (HbS) crystallizes readily at low oxygen tension.
In consequence, erythrocytes from homozygotes change from the normal discoid shape to a sickled shape when the oxygen tension is low and these sickled cells become trapped in capillaries or damaged in transit, leading to severe anaemia.
In heterozygotes, the disadvantages of the abnormal haemoglobin are apparently outweighed by increased resistance to Plasmodium falciparum malaria, probably because parasitised cells tend to sickle and are then removed from circulation.
Symptoms include joint pain, acute abdominal pain, and ulcerations of the lower extremities.
Origin: Gr. Haima = blood
(18 Nov 1997)
sickle cell haemoglobin <haematology> Haemoglobin S is an abnormal version of the protein haemoglobin.
The sixth amino acid of the normal beta chain, glutamic acid, is replaced by valine with gluconic acid. This mutation causes the red blood cell to take on a sickle shape, and is the cause of the sickle cell trait condition (when the individual is heterozygous for this mutant haemoglobin) and the disease of sickle cell anaemia (when the individual is homozygous for this mutant haemoglobin).
(09 Oct 1997)
sickle cell prep <haematology, investigation> A test which looks at red blood cells under the microscope to detect sickle cells after an agent which lowers the oxygen content of the sample is added.
A positive test is result is determined by the presence of sickle cells. Abnormal results indicate sickle cell anaemia or sickle cell trait.
(27 Sep 1997)
sickle cell retinopathy A condition marked by dilation and tortuosity of retinal veins, and by microaneurysms and retinal haemorrhages; advanced stages may show neovascularization, vitreous haemorrhage, or retinal detachment.
(05 Mar 2000)
sickle cell test <investigation> A test which looks at red blood cells under the microscope to detect sickle cells after an agent which lowers the oxygen content of the sample is added. A positive test is result is determined by the presence of sickle cells. Abnormal results indicate sickle cell anaemia or sickle cell trait.
(27 Sep 1997)
sickle cell-thalassaemia disease Anaemia, clinically resembling sickle cell anaemia, in which individuals are compound heterozygous for the sickle cell gene and a thalassaemia gene; about 60 to 80% of haemoglobin is Hb S, up to 20% Hb F, and the remainder Hb anaemia.
Synonym: sickle cell-thalassaemia disease.
(05 Mar 2000)
sickle cell trait <haematology> This condition occurs in people who have one of two possible genes (i.e., they are heterozygous forthe allele) that code for the defective haemoglobin responsible for sickle cell anaemia.
The coditionis diagnosed by exposing an individual's red blood cells to a low oxygen environment, if the trait is present, the cells will turn to a sickle shape. People with this trait may suffer milder symptoms of sickle cell anaemia, or may have no symptoms. Some scientists believe the trait actually provides an evolutionary advantage in tropical environments because the slightly altered shape of the blood cells causes a person to be more resistant to malaria.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fetal hemoglobin
    žƼº Ç÷»ö¼Ò;žƼº Çì¸ð±Û·Îºó
  • hemoglobin
    Çì¸ð±Û·Îºó;Ç÷»ö¼Ò
  • sickle
    ³´
  • hammer and sickle
    (ÇØ¸Ó¿Í ³´À¸·Î µÈ)¼Ò·Ã ±¹±â
  • sickle
    (ÀÛÀº) ³´;~ cell anemia °âÇü ÀûÇ÷±¸ ºó
  • cell
    ¼¼Æ÷
  • HeLa cell
    Èú·¯ ¼¼Æ÷(¿¬±¸¿ëÀ¸·Î ¹è¾çµÇ°í ÀÖ´Â ¾Ï¼¼Æ÷ÀÇ ÀÏÁ¾)
  • blood cell
    Ç÷±¸
  • brain cell
    ³ú½Å°æ¼¼Æ÷
  • cadmium cell
    Ä«µå¹Å ÀüÁö
  • cell
    ÀÛÀº¹æ;¾ÏÀÚ(¼öµµ¿ø ºÎ¼ÓÀÇ);»ç½Ç;¿ÀµÎ¸·Áý;¹«´ý;(±³µµ¼ÒÀÇ)µ¶¹æ;(¹úÁýÀÇ)±¸¸Û;²É°¡·çÁÖ¸Ó´Ï;ÀüÁö;¼¼Æ÷;(Á¶Á÷³»ÀÇ)ÀÛÀº °øµ¿;¼¼Æ÷(°ø»ê´ç µîÀÇ);°¡½ºÅë(±â±¸ÀÇ);ºñÆ®ÀÇ ±â¾ï¼ÒÀÚ;µ¶¹æ»ìÀÌÇÏ´Ù;ÀÛÀº ¹æ¿¡ Ʋ¾î¹ÚÈ÷´Ù
  • cell body
    ¼¼Æ÷ÀÇ
  • cell cycle
    ¼¼Æ÷ÁÖ±â;ºÐ¿­ÁÖ±â
  • cell division
    ¼¼Æ÷ºÐ¿­
  • cell fusion
    ¼¼Æ÷À¶ÇÕ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á